Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention
Open Access
Abstract
The prevention and appropriate management of venous thromboembolism in cancer patients is of paramount importance. However, the literature data report an underestimation of this major problem in patients with gynecological cancers, with an inconsistent venous thromboembolism risk assessment and prophylaxis in this patient setting. This narrative review provides a comprehensive overview of the available evidence regarding the management of venous thromboembolism in cancer patients, focusing on the specific context of gynecological tumors, exploring the literature discussing risk factors, risk assessment, and pharmacological prophylaxis. We found that the current understanding and management of venous thromboembolism in gynecological malignancy is largely based on studies on solid cancers in general. Hence, further, larger, and well-designed research in this area is needed.Keywords
This publication has 111 references indexed in Scilit:
- External validation of a novel electronic risk score for cancer‐associated thrombosis in a comprehensive cancer centerAmerican Journal of Hematology, 2023
- Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With CancerJAMA Network Open, 2023
- Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerJournal of Thrombosis and Thrombolysis, 2021
- Trends in venous thromboembolism prophylaxis in gynecologic surgery for benign and malignant indicationsArchives of Gynecology and Obstetrics, 2020
- Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant NeoplasmJAMA Network Open, 2020
- A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn scoreResearch and Practice in Thrombosis and Haemostasis, 2020
- The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patientsAmerican Journal of Obstetrics and Gynecology, 2016
- Mutant IDH1 and thrombosis in gliomasActa Neuropathologica, 2016
- Effect of all‐trans‐Retinoic acid on the hypercoagulable state of patients with breast cancerAmerican Journal of Hematology, 2002
- Pathogenesis of Thrombosis in Patients with MalignancyInternational Journal of Hematology, 2001